Showing results (221-230 of 675) with videos related to

Sort By:
Pageof 68
Proteins|October 13, 2011
Effects of the Val211Gly substitution on molecular dynamics of the CMY-2 cephalosporinase: implications on hydrolysis of expanded-spectrum cephalosporinsStathis D Kotsakis, Leonidas S Tzouvelekis, Efthymia Petinaki, et al.
Endocrinology|June 1, 1993
Bisphenol-A: an estrogenic substance is released from polycarbonate flasks during autoclavingA V Krishnan, P Stathis, S F Permuth, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|April 1, 1994
Influence of sprint training on human skeletal muscle purine nucleotide metabolismC G Stathis, M A Febbraio, M F Carey, et al.
Medical Image Computing and Computer-Assisted Intervention : MICCAI ... International Conference on Medical Image Computing and Computer-Assisted Intervention|October 1, 2010
DTI based diagnostic prediction of a disease via pattern classificationMadhura Ingalhalikar, Stathis Kanterakis, Ruben Gur, et al.
Marine Drugs|August 8, 2013
Hepatotoxic seafood poisoning (HSP) due to microcystins: a threat from the ocean?Katerina Vareli, Walter Jaeger, Anastasia Touka, et al.
FEMS Microbiology Ecology|May 8, 2023
Veterinary drug albendazole inhibits root colonization and symbiotic function of the arbuscular mycorrhizal fungus Rhizophagus irregularisEleni Gkimprixi, Stathis Lagos, Christina N Nikolaou, et al.
The Journal of Physical Chemistry. A|April 21, 2025
Anthracene Photodegradation Kinetics in Salty Aqueous and Organic SolutionsMichael Nicklin, Alexa A Stathis, Kyle Blaha, et al.
Journal of Experimental Botany|April 11, 2025
Using functional structural models to design architectural ideotypes of grapevine to cope with extreme heat and water stresses: a multi-criteria analysisMathilde Millan, Rami Albasha, Stathis Delivorias, et al.
Life Sciences|January 1, 1995
[3H]A-69024: a non-benzazepine ligand for in vitro and in vivo studies of dopamine D1 receptorsM Kassiou, U A Scheffel, J L Musachio, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 4, 2010
Choice of starting dose for molecularly targeted agents evaluated in first-in-human phase I cancer clinical trialsChristophe Le Tourneau, Anastasios Stathis, Laura Vidal, et al.
Pageof 68